Oral and IV Contrast Agents for the CT Portion of PET/CT

被引：20
|
作者：
Cronin, Carmel G. [1 ,2 ]
Prakash, Priyanka [1 ,2 ]
Blake, Michael A. [1 ,2 ]
机构：
[1] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA 02114 USA
来源：
AMERICAN JOURNAL OF ROENTGENOLOGY | 2010年 / 195卷 / 01期
关键词：
contrast material; IV contrast agents; oral contrast agents; PET/CT; small bowel; EMISSION-TOMOGRAPHY; ENHANCED CT; FDG-PET/CT; NONENHANCED CT; RECTAL-CANCER; PROTOCOLS; IMPACT;
D O I：
10.2214/AJR.09.3844
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
[No abstract available]
引用
收藏
页码：W5 / W13
页数：9
相关论文
共 50 条
  • [31] IV Leiomyomatosis on FDG PET/CT
    Jin, Xiaona
    Li, Fang
    Lu, Zhaohui
    Cheng, Wuying
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (07) : 580 - 582
  • [32] The effect of oral contrast on large bowel activity in FDG-PET/CT
    Hideki Otsuka
    Michael M. Graham
    Akiko Kubo
    Hiromu Nishitani
    Annals of Nuclear Medicine, 2005, 19 : 101 - 108
  • [33] The effect of oral contrast on large bowel activity in FDG-PET/CT
    Otsuka, H
    Graham, MM
    Kubo, A
    Nishitani, H
    ANNALS OF NUCLEAR MEDICINE, 2005, 19 (02) : 101 - 108
  • [34] Clinical experience with a commercially available negative oral contrast medium in PET/CT
    Debatin, J
    ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 2005, 177 (06): : 779 - 779
  • [35] The incidence of pulmonary embolism and associated FDG-PET findings on IV contrast enhanced PET/CT
    Flavell, Robert
    Behr, Spencer
    Brunsing, Ryan
    Naeger, David
    Pampaloni, Miguel Hernandez
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [36] Oral contrast medium in PET/CT: should you or shouldn't you?
    Groves, AM
    Kayani, I
    Dickson, JC
    Townsend, C
    Croasdale, I
    Syed, R
    Nagabushan, N
    Hain, SF
    Ell, PJ
    Bomanji, JB
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 (10) : 1160 - 1166
  • [37] Oral contrast medium in PET/CT: should you or shouldn’t you?
    Ashley M. Groves
    Irfan Kayani
    John C. Dickson
    Caroline Townsend
    Ian Croasdale
    Rizwan Syed
    Nagesh Nagabushan
    Sharon F. Hain
    Peter J. Ell
    Jamshed B. Bomanji
    European Journal of Nuclear Medicine and Molecular Imaging, 2005, 32 : 1160 - 1166
  • [38] Optimized IV contrast administration protocols for diagnostic FDG-PET/CT imaging
    Beyer, T
    Antoch, G
    Fehlings, T
    Rosenbaum, S
    Freudenberg, LS
    Stattaus, J
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S286 - S286
  • [39] Toxicity of MRI and CT contrast agents
    Hasebroock, Kendra M.
    Serkova, Natalie J.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2009, 5 (04) : 403 - 416
  • [40] Quantifying the effect of IV contrast media on integrated PET/CT: Clinical evaluation.
    Mawlawi, O
    Erasmus, JJ
    Munden, RF
    Pan, T
    Knight, AE
    Macapinlac, HA
    Podoloff, DA
    Chasen, M
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2006, 186 (02) : 308 - 319
12345